Authors
»
[No authors listed]
Category
»
Primary study
Registry of Trials»Iranian Registry of Clinical Trials
Year
»
2017
INTERVENTION: Acceptance & Commitment Therapy(ACT) Behavior Cognitive‐Behavior Therapy(CBT) Intervention 1: Acceptance & Commitment Therapy(ACT). Intervention 2: Cognitive‐Behavior Therapy(CBT). Intervention 3: No intervention. No intervention CONDITION: ????F43.0 A transient disorder that develops in an individual without any other apparent mental disorder in response to exceptional physical and mental stress and that usually subsides within hours or days. Individual vulnerability and coping capacity play a role i Anxiety that is generalized and persistent but not restricted to, or even strongly predominating in, any particular environmental circumstances (i.e. it is Condition 1: Multiple Sclerosis. Condition 2: Fatigue. Condition 3: Depression. Condition 4: Stress. Condition 5: Anxiety. ; General physical deterioration, Lethargy, Tiredness ; Two or three of the above symptoms are usually present. The patient is usually distressed by these but will probably be able to continue with most activities. ; A transient disorder that develops in an individual without any other apparent mental disorder in response to exceptional physical and mental stress and that usually subsides within hours or days. Individual vulnerability and coping capacity play a role i ; Anxiety that is generalized and persistent but not restricted to, or even strongly predominating in, any particular environmental circumstances (i.e. it is General physical deterioration, Lethargy, Tiredness Two or three of the above symptoms are usually present. The patient is usually distressed by these but will probably be able to continue with most activities. PRIMARY OUTCOME: Anxiety. Timepoint: Before the intervention (pre‐test), immediately after the intervention (post‐test), after one month and half of the intervention (follow‐up 1), after three month of the intervention(follow‐up 2). Method of measurement: Depression, Anxiety & Stress Scale(DASS). Depresiion. Timepoint: Before the intervention (pre‐test), immediately after the intervention (post‐test), after one month and half of the intervention (follow‐up 1), after three month of the intervention(follow‐up 2). Method of measurement: Depression, Anxiety & Stress Scale(DASS). Fatigue. Timepoint: Before the intervention (pre‐test), immediately after the intervention (post‐test), after one month and half of the intervention (follow‐up 1), after three month of the intervention(follow‐up 2). Method of measurement: Based on Fatigue in M.S patient Questionnaire. Stress. Timepoint: Before the intervention (pre‐test), immediately after the intervention (post‐test), after one month and half of the intervention (follow‐up 1), after three month of the intervention(follow‐up 2). Method of measurement: Depression, Anxiety & Stress Scale(DASS). SECONDARY OUTCOME: Quality of Life. Timepoint: Before the intervention (pre‐test), immediately after the intervention (post‐test), after one month and half of the intervention (follow‐up 1), after three month of the intervention(follow‐up 2). Method of measurement: M.s Quality of Life scale. Resilience. Timepoint: Before the intervention (pre‐test), immediately after the intervention (post‐test), after one month and half of the intervention (follow‐up 1), after three month of the intervention(follow‐up 2). Method of measurement: Connor‐ Davidson Resilience Scale. INCLUSION CRITERIA: INCLUSION CRITERIA: 1‐20‐40 years old‐rage 2‐Ability of orderly participation in therapy sessions 3‐Conscious satisfaction of participation in research plan 1‐Having serious signs of MS 2‐Affliction to or suffering from extreme or serious physical or mental disease 3‐Not intend to participation in therapy process
Epistemonikos ID: 1bf6f00defcafe1e14893614e8ca1203df60a026
First added on: Mar 31, 2022